Different patterns of in vivo pro-oxidant states in a set of cancer- or aging-related genetic diseases

Free Radical Biology and Medicine

Volumn 44, Issue 4, 2008, Pages 495-503

  Lloret, Ana ^a   Calzone, Rita ^b   Dunster, Christina ^c   Manini, Paola ^d   d'Ischia, Marco ^d   Degan, Paolo ^e   Kelly, Frank J ^c   Pallardó, Federico V ^a   Zatterale, Adriana ^b   Pagano, Giovanni ^f  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Elena d'Aosta Hospital   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

^f Italian Association for Fanconi Anemia Research   (Italy)

Author keywords

Antioxidants; Cancer prone diseases; Chromosomal instability; DNA damage; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ASCORBIC ACID; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYOXAL; METHYLGLYOXAL; OXIDIZING AGENT; URIC ACID;

AGING; ATAXIA TELANGIECTASIA; BLOOD LEVEL; BLOOM SYNDROME; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL FEATURE; COMPARATIVE STUDY; DOWN SYNDROME; FANCONI ANEMIA; GENETIC DISORDER; HUMAN; LEUKOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; URINE LEVEL; WERNER SYNDROME; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; AGED; ATAXIA TELANGIECTASIA; BLOOM SYNDROME; CHILD; DEOXYGUANOSINE; DNA DAMAGE; DOWN SYNDROME; FANCONI ANEMIA; FEMALE; GLUTATHIONE; GLYOXAL; HUMANS; MALE; MIDDLE AGED; PYRUVALDEHYDE; REACTIVE OXYGEN SPECIES; WERNER SYNDROME; XERODERMA PIGMENTOSUM;

EID: 38649125578     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.10.046     Document Type: Review

References (84)

1. Pagano G. Oxidative stress in cancer prone diseases. In: Singh K.K. (Ed). Oxidative stress, disease and cancer (2005), Imperial College Press, London 761-788
2. Brooksbank B.W., and Balasz R. Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Exp. Brain Res. 16 (1984) 37-44
3. Kedziora J., and Bartosz G. Down's syndrome: a pathology involving the lack of balance of reactive oxygen species. Free Radic. Biol. Med. 4 (1988) 317-330
4. Groner Y., Elroy-Stein O., Avraham K.B., Schickler M., Knobler H., Minc-Golomb D., Bar-Peled O., Yarom R., and Rotshenker S. Cell damage by excess CuZnSOD and Down's syndrome. Biomed. Pharmacother. 48 (1994) 231-240
5. Jovanovic S.V., Clements D., and MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic. Biol. Med. 25 (1998) 1044-1048
6. Žitňanová I., Korytar P., Aruoma O.I., Šustrová M., Garaiová I., Muchová J., Kalnovičová T., Pueschel S., and Duračková Z. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?. Clin. Chim. Acta 341 (2004) 139-146
7. Gualandri W., Gualandri L., Demartini G., Esposti R., Marthyn P., Volonté S., Stangoni L., Borgonovo M., and Fraschini F. Redox balance in patients with Down's syndrome before and after dietary supplementation with alpha-lipoic acid and l-cysteine. Int. J. Clin. Pharmacol. Res. 23 (2003) 23-30
8. Pallardó F.V., Degan P., d'Ischia M., Kelly F.J., Zatterale A., Calzone R., Castello G., Fernandez-Delgado R., Dunster C., Lloret A., Manini P., Pisanti M.A., Vuttariello E., and Pagano G. Higher age-related prooxidant state in young Down syndrome patients indicates accelerated aging. Biogerontology 7 (2006) 211-220
9. Zana M., Szecsenyi A., Czibula A., Bjelik A., Juhasz A., Rimanoczy A., Szabo K., Vetro A., Szucs P., Varkonyi A., Pakaski M., Boda K., Rasko I., Janka Z., and Kalman J. Age-dependent oxidative stress-induced DNA damage in Down's lymphocytes. Biochem. Biophys. Res. Commun. 345 (2006) 726-733
10. Kruyt F.A., Hoshino T., Liu J.M., Joseph P., Jaiswal A.K., and Youssoufian H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 92 (1998) 3050-3056
11. Cumming R.C., Lightfoot J., Beard K., Youssoufian H., O'Brien P.J., and Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat. Med. 7 (2001) 814-820
12. Futaki M., Igarashi T., Watanabe S., Kajigaya S., Tatsuguchi A., Wang J., and Liu J.M. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 23 (2002) 67-72
13. Pagano G., and Youssoufian H. Fanconi's anaemia proteins: concurrent roles in cell protection against oxidative damage. BioEssays 25 (2003) 589-595
14. Park S.J., Ciccone S.L., Beck B.D., Hwang B., Freie B., Clapp D.W., and Lee S.H. Oxidative stress/damage induces multimerization and interaction of Fanconi anemia proteins. J. Biol. Chem. 279 (2004) 30053-30059
15. Zhang X., Li J., Sejas D.P., Rathbun K.R., Bagby G.C., and Pang Q. The Fanconi anemia proteins functionally interact with the protein kinase regulated by RNA (PKR). J. Biol. Chem. 279 (2004) 43910-43919
16. Joenje H., Arwert F., Eriksson A.W., de Koning H., and Oostra A.B. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 290 (1981) 142-143
17. Ruppitsch W., Meisslitzer C., Hirsch-Kauffmann M., and Schweiger M. Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane. FEBS Lett. 422 (1998) 99-102
18. Kontou M., Adelfalk C., Ramirez M.H., Ruppitsch W., Hirsch-Kauffmann M., and Schweiger M. Overexpressed thioredoxin compensates Fanconi anemia related chromosomal instability. Oncogene 21 (2002) 2406-2412
19. Mukhopadhyay S.S., Leung K.S., Hicks M.J., Hastings P.J., Youssoufian H., and Plon S.E. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J. Cell Biol. 175 (2006) 225-235
20. Pagano G., and Ahmad S.I. Fanconi anaemia and oxidative stress: cellular and clinical phenotypes. In: Ahmad S.I., and Kirk S. (Eds). Molecular mechanisms of Fanconi anemia (2006), Springer Science, New York 82-91
21. Pagano G., Manini P., and Bagchi D. Oxidative stress-related mechanisms in chromium(VI)-induced toxicity to Fanconi anemia cells. Environ. Health Perspect. 111 (2003) 1699-1703
22. Takeuchi T., and Morimoto K. Increased formation of 8-hydroxydeoxyguanosine, an oxidative DNA damage, in lymphoblasts from Fanconi's anemia patients due to possible catalase deficiency. Carcinogenesis 14 (1993) 1115-1120
23. Degan P., Bonassi S., De Caterina M., Korkina L.G., Pinto L., Scopacasa F., Zatterale A., Calzone R., and Pagano G. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 16 (1995) 735-742
24. Pagano G., Degan P., d'Ischia M., Kelly F.J., Pallardó F.V., Zatterale A., Anak S.S., Akişi{dotless}k E.E., Beneduce G., Calzone R., De Nicola E., Dunster C., Lloret A., Manini P., Nobili B., Saviano A., Vuttariello E., and Warnau M. Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients. Carcinogenesis 25 (2004) 1899-1909
25. Barzilai A., Rotman G., and Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amsterdam) 1 (2002) 3-25
26. Watters D.J. Oxidative stress in ataxia telangiectasia. Redox Rep. 8 (2003) 23-29
27. Ziv S., Brenner O., Amariglio N., Smorodinsky N.I., Galron R., Carrion D.V., Zhang W., Sharma G.G., Pandita R.K., Agarwal M., Elkon R., Katzin N., Bar-Am I., Pandita T.K., Kucherlapati R., Rechavi G., Shiloh Y., and Barzilai A. Impaired genomic stability and increased oxidative stress exacerbate different features of ataxia-telangiectasia. Hum. Mol. Genet. 14 (2005) 2929-2943
28. Sheridan R.B., and Huang P.C. Superoxide dismutase and catalase activities in ataxia telangiectasia and normal fibroblast cell extracts. Mutat. Res. 61 (1979) 381-386
29. Aksoy Y., Sanal O., Metin A., Tezcan I., Ersoy F., Ogus H., and Ozer N. Antioxidant enzymes in red blood cells and lymphocytes of ataxia-telangiectasia patients. Turk. J. Pediatr. 46 (2004) 204-207
30. Kamsler A., Daily D., Hochman A., Stern N., Shiloh Y., Rotman G., and Barzilai A. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61 (2001) 1849-1854
31. Chen P., Peng C., Luff J., Spring K., Watters D., Bottle S., Furuya S., and Lavin M.F. Oxidative stress is responsible for deficient survival and dendritogenesis in Purkinje neurons from ataxia-telangiectasia mutated mutant mice. J. Neurosci. 23 (2003) 11453-11460
32. Liu N., Stoica G., Yan M., Scofield V.L., Qiang W., Lynn W.S., and Wong P.K. ATM deficiency induces oxidative stress and endoplasmic reticulum stress in astrocytes. Lab. Invest. 85 (2005) 1471-1480
33. Browne S.E., Roberts II L.J., Dennery P.A., Doctrow S.R., Beal M.F., Barlow C., and Levine R.L. Treatment with a catalytic antioxidant corrects the neurobehavioral defect in ataxia-telangiectasia mice. Free Radic. Biol. Med. 36 (2004) 938-942
34. Erker L., Schubert R., Yakushiji H., Barlow C., Larson D., Mitchell J.B., and Wynshaw-Boris A. Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor. Hum. Mol. Genet. 14 (2005) 1699-1708
35. Reliene R., and Schiestl R.H. Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice. J. Nutr. 137 (2007) 229S-232S
36. Reichenbach J., Schubert R., Schindler D., Muller K., Bohles H., and Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal. 4 (2002) 465-469
37. Reichenbach J., Schubert R., Schwan C., Muller K., Bohles H.J., and Zielen S. Anti-oxidative capacity in patients with ataxia telangiectasia. Clin. Exp. Immunol. 117 (1999) 535-539
38. Degan P., d'Ischia M., Pallardó F.V., Zatterale A., Brusco A., Calzone R., Cavalieri S., Kavakli{dotless} K., Lloret A., Manini P., Pisanti M.A., Vuttariello E., and Pagano G. Glutathione levels in blood from ataxia telangiectasia patients suggest in vivo adaptive mechanisms to oxidative stress. Clin. Biochem. 40 (2007) 666-670
39. Nicotera T.M., Notaro J., Notaro S., Schumer J., and Sandberg A.A. Elevated superoxide dismutase in Bloom's syndrome: a genetic condition of oxidative stress. Cancer Res. 49 (1989) 5239-5243
40. Nicotera T., Thusu K., and Dandona P. Elevated production of active oxygen in Bloom's syndrome cell lines. Cancer Res. 53 (1993) 5104-5107
41. Poot M., Rudiger H.W., and Hoehn H. Detection of free radical-induced DNA damage with bromodeoxyuridine/Hoechst flow cytometry: implications for Bloom's syndrome. Mutat. Res. 238 (1990) 203-207
42. Zatterale A., Kelly F.J., Degan P., d'Ischia M., Pallardó F.V., Calzone R., Dunster C., Lloret A., Manini P., Coǧulu O., Kavakli{dotless} K., and Pagano G. Oxidative stress biomarkers in four Bloom syndrome patients and in their parents suggest in vivo redox abnormalities. Clin. Biochem. 40 (2007) 110-1103
43. Indig F.E., Partridge J.J., von Kobbe C., Aladjem M.J., Latterich M., and Bohr V.A. Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion. J. Struct. Biol. 146 (2004) 251-259
44. Karmakar P., Piotrowski J., Brosh R.M., Sommers J.A., Miller S.P., Cheng W.H., Snowden C.M., Ramsden D.A., and Bohr V.A. Werner protein is a target of DNA-dependent protein kinase in vivo and in vitro, and its catalytic activities are regulated by phosphorylation. J. Biol. Chem. 277 (2002) 18291-18302
45. Kashino G., Kodama S., Nakayama Y., Suzuki K., Fukase K., Goto M., and Watanabe M. Relief of oxidative stress by ascorbic acid delays cellular senescence of normal human and Werner syndrome fibroblast cells. Free Radic. Biol. Med. 35 (2003) 438-443
46. von Kobbe C., May A., Grandori C., and Bohr V.A. Werner syndrome cells escape hydrogen peroxide-induced cell proliferation arrest. FASEB J. 18 (2004) 1970-1972
47. Pagano G., Zatterale A., Degan P., d'Ischia M., Kelly F.J., Pallardó F.V., Calzone R., Dunster C., Giudice A., Lloret A., Manini P., Masella R., Vuttariello E., Ki{dotless}li{dotless}nç Y., and Warnau M. In vivo prooxidant state in Werner syndrome patients. Free Radic. Res. 39 (2005) 529-533
48. Yokote K., Honjo S., Kobayashi K., Fujimoto M., Kawamura H., Mori S., and Saito Y. Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone. J. Am. Geriatr. Soc. 52 (2004) 1582-1583
49. Pagano G., Zatterale A., Degan P., d'Ischia M., Kelly F.J., Pallardó F.V., and Kodama S. Multiple involvement of oxidative stress in Werner syndrome phenotype. Biogerontology 6 (2005) 233-243
50. Dusinska M., Dzupinkova Z., Wsolova L., Harrington V., and Collins A.R. Possible involvement of XPA in repair of oxidative DNA damage deduced from analysis of damage repair and genotype in a human population study. Mutagenesis 21 (2006) 205-211
51. Hayashi M., Araki S., Kohyama J., Shioda K., and Fukatsu R. Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome. Brain Develop. 27 (2005) 34-38
52. Arbault S., Sojic N., Bruce D., Amatore C., Sarasin A., and Vuillaume M. Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts: real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes. Carcinogenesis 25 (2004) 509-515
53. de Waard H., de Wit J., Gorgels T.G., van den Aardweg G., Andressoo J.O., Vermeij M., van Steeg H., Hoeijmakers J.H., and van der Horst G.T. Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair (Amsterdam) 2 (2003) 13-25
54. Le Page F., Kwoh E.E., Avrutskaya A., Gentil A., Leadon S.A., Sarasin A., and Cooper P.K. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome. Cell 123 (2005) 711
55. Vuillaume M., Daya-Grosjean L., Vincens P., Pennetier J.L., Tarroux P., Baret A., Calvayrac R., Taieb A., and Sarasin A. Striking differences in cellular catalase activity between two DNA repair-deficient diseases: xeroderma pigmentosum and trichothiodystrophy. Carcinogenesis 13 (1992) 321-328
56. Satge D., Sommelet D., Geneix A., Nishi M., Malet P., and Vekemans M. A tumor profile in Down syndrome. Am. J. Med. Genet. 78 (1998) 207-216
57. Alter B.P. Fanconi anemia and malignancies. Am. J. Hematol. 53 (1996) 99-110
58. Duker N.J. Chromosome breakage syndromes and cancer. Am. J. Med. Genet. 115 (2002) 125-129
59. Chen L., and Oshima J. Werner syndrome. J. Biomed. Biotechnol. 2 (2002) 46-54
60. Ames B.N. Endogenous oxidative DNA damage, aging, and cancer. Free Radic. Res. Commun. 7 (1989) 121-128
61. Floyd R.A. The role of 8-hydroguanine in carcinogenesis. Carcinogenesis 9 (1990) 1447-1450
62. Giannattasio A., Girotti M., Williams K., Hall L., and Bellastella A. Puberty influences expression of phospholipid hydroperoxide glutathione peroxidase (GPX4) in rat testis: probable hypophysis regulation of the enzyme in male reproductive tract. J. Endocrinol. Investig. 20 (1997) 439-444
63. Aragno M., Parola S., Brignardello E., Mauro A., Tamagno E., Manti R., Danni O., and Boccuzzi G. Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats. Diabetes 49 (2000) 1924-1931
64. Borras C., Gambini J., Gomez-Cabrera M.C., Sastre J., Pallardo F.V., Mann G.E., and Vina J. 17β-Oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFκB cascade. Aging Cell 4 (2005) 113-118
65. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
66. Olinski R., Gackowski D., Foksinski M., Rozalski R., Roszkowski K., and Jaruga P. Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic. Biol. Med. 33 (2002) 192-200
67. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279 (2004) 42351-42354
68. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23 Suppl. 1 (1993) 118-126
69. Wolff S.P. Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br. Med. Bull. 49 (1993) 642-652
70. Marsili S., Salganik R.I., Albright C.D., Freel C.D., Johnsen S., Peiffer R.L., and Costello M.J. Cataract formation in a strain of rats selected for high oxidative stress. Exp. Eye Res. 79 (2004) 595-612
71. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., and Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106 (2002) 927-932
72. von Kobbe C., Thoma N.H., Czyzewski B.K., Pavletich N.P., and Bohr V.A. Werner syndrome protein contains three structure-specific DNA binding domains. J. Biol. Chem. 278 (2003) 52997-53006
73. Ahn B., Harrigan J.A., Indig F.E., Wilson D.M., and Bohr V.A. Regulation of WRN helicase activity in human base excision repair. J. Biol. Chem. 279 (2004) 53465-53474
74. von Kobbe C., Harrigan J.A., May A., Opresko P.L., Dawut L., Cheng W.H., and Bohr V.A. Central role for the Werner syndrome protein/poly(ADP-ribose) polymerase 1 complex in the poly(ADP-ribosyl)ation pathway after DNA damage. Mol. Cell. Biol. 23 (2003) 8601-8613
75. Harrigan J.A., Opresko P.L., von Kobbe C., Kedar P.S., Prasad R., Wilson S.H., and Bohr V.A. The Werner syndrome protein stimulates DNA polymerase beta strand displacement synthesis via its helicase activity. J. Biol. Chem. 278 (2003) 22686-22695
76. Fortini P., Pascucci B., Parlanti E., D'Errico M., Simonelli V., and Dogliotti E. 8-Oxoguanine DNA damage: at the crossroad of alternative repair pathways. Mutat. Res. 531 (2003) 127-139
77. Hisama F.M., Chen Y.H., Meyn M.S., Oshima J., and Weissman S.M. WRN or telomerase constructs reverse 4-nitroquinoline 1-oxide sensitivity in transformed Werner syndrome fibroblasts. Cancer Res. 60 (2000) 2372-2376
78. Borrás C., Esteve J.M., Viña J.R., Sastre J., Viña J., and Pallardó F.V. Glutathione regulates telomerase activity in 3T3 fibroblasts. J. Biol. Chem. 279 (2004) 34332-34335
79. Armstrong L., Saretzki G., Peters H., Wappler I., Evans J., Hole N., von Zglinicki T., and Lako M. Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 23 (2005) 516-529
80. Lee M.K., Hande M.P., and Sabapathy K. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J. Cell Sci. 118 (2005) 819-829
81. +-ATPase isoform expression in rat heart. Antioxid. Redox Signal. 6 (2004) 914-923
82. Orren D.K., Machwe A., Karmakar P., Piotrowski J., Cooper M.P., and Bohr V.A. A functional interaction of Ku with Werner exonuclease facilitates digestion of damaged DNA. Nucleic Acids Res. 29 (2001) 1926-1934
83. Das A., Boldogh I., Wan Lee J., Harrigan J.A., Hegde M.L., Piotrowski J., de Souza Pinto N., Ramos W., Greenberg M.M., Hazra T.K., Mitra S., and Bohr V.A. The human Werner syndrome protein stimulates repair of oxidative DNA base damage by the DNA glycosylase NEIL1. J. Biol. Chem. 282 (2007) 26591-26602
84. Chen J., Li D., Zhang X., and Mehta J.L. Tumor necrosis factor-alpha-induced apoptosis of human coronary artery endothelial cells: modulation by the peroxisome proliferator-activated receptor-gamma ligand pioglitazone. J. Cardiovasc. Pharmacol. Ther. 9 (2004) 35-41